COTY INC. COTY
Founded in 1904, Coty Inc. is one of the world's largest beauty companies with an iconic portfolio of brands across fragrance, color cosmetics, and skin and body care.
We have been engaged in the process of strategic planning and portfolio assessment designed to position the Company for consistent, profitable growth. In September 2025, we announced a strategic review of the Company's consumer beauty business, including its mass color cosmetics business and associated brands and the Company's distinct Brazil business comprised of local Brazilian brands. In January 2026, Markus Strobel was appointed as our Executive Chairman and Interim Chief Executive Officer, and in March 2026, the Company's Board of Directors appointed five new independent directors. While our long-term objectives remain focused on value creation, growth, profitability, and deleveraging, our Interim CEO continues to conduct a comprehensive review of the business to assess opportunities to enhance performance, strengthen competitive positioning, and improve execution across key areas. We are focused on leveraging our leadership position and capabilities in global fragrances to fuel expansion. We will continue strengthening our presence in a limited number of structurally profitable and growing beauty categories, in growth channels such as e-commerce and the Travel Retail channel, all while continuing to deliver against our key sustainability priorities. We have sharpened our priorities to capitalize on structural tailwinds in the fragrance market, while responding to recent performance challenges. Through our Coty.Curated strategic framework, we are focused on fewer, bigger and better initiatives, greater marketing sufficiency, improved supply reliability, stronger consumer engagement and advocacy, and more productive innovation and portfolio choices. In both Prestige and Consumer Beauty, we are focused on returning to market share growth, accelerating data-driven operations powered by AI, and improving our advocacy capability and execution. We are also evaluating our central organization, manufacturing and asset base, and certain market structures to adjust our scope and size for our future business.
Valuation FY2026 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.81B | $5.89B | $6.12B | $5.55B | $5.30B | $4.63B | $4.72B | $6.29B | $6.84B | $7.65B |
| Cost of revenue | $2.15B | $2.07B | $2.18B | $2.01B | $1.94B | $1.86B | $1.99B | $2.50B | $2.72B | $3.03B |
| Gross profit | $3.65B | $3.82B | $3.94B | $3.55B | $3.37B | $2.77B | $2.73B | $3.79B | $4.12B | $4.62B |
| R&D | $121.2M | $123.0M | $126.8M | $105.2M | $97.3M | $96.5M | $93.4M | $98.5M | $108.1M | $139.2M |
| SG&A | $3.11B | $3.10B | $3.16B | $2.82B | $2.88B | $2.36B | $3.12B | $3.47B | $3.81B | $4.04B |
| Operating income | -$81.5M | $241.1M | $546.7M | $543.7M | $240.9M | -$48.6M | -$1.24B | -$3.69B | -$155.5M | -$420.9M |
| Interest expense | $184.2M | $227.0M | $251.6M | $261.1M | $241.2M | $231.8M | $233.3M | $252.0M | $222.7M | $219.6M |
| Pre-tax income | -$610.2M | -$344.8M | $204.5M | $704.8M | $426.8M | -$239.8M | -$1.47B | -$3.95B | -$394.5M | -$658.0M |
| Income tax | $20.0M | $5.4M | $95.1M | $181.6M | $164.8M | $172.0M | $377.7M | $54.8M | $32.2M | $259.5M |
| Net income | -$604.8M | -$367.9M | $89.4M | $508.2M | $259.5M | -$201.3M | -$1.01B | -$3.78B | -$168.8M | -$422.2M |
| EPS, basic | -0.70 | -0.44 | 0.09 | 0.58 | 0.08 | -0.40 | -1.33 | -5.04 | -0.23 | -0.66 |
| EPS, diluted | -0.70 | -0.44 | 0.09 | 0.57 | 0.08 | -0.40 | -1.33 | -5.04 | -0.23 | -0.66 |
| Shares, diluted (wtd. avg.) | 877.4M | 870.9M | 883.4M | 886.5M | 834.1M | 764.8M | 759.1M | 751.2M | 749.7M | 642.8M |
Balance sheet
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $176.1M | $257.1M | $320.6M | $283.8M | $263.8M | $310.4M | $352.0M | $380.4M | $362.2M | $570.7M |
| Receivables | $525.8M | $526.4M | $441.6M | $360.9M | $364.6M | $348.0M | $440.1M | $858.9M | $1.54B | $1.47B |
| Inventory | $838.7M | $794.5M | $764.1M | $853.4M | $661.5M | $650.8M | $678.2M | $860.1M | $1.15B | $1.05B |
| Total current assets | $1.92B | $1.95B | $1.96B | $2.05B | $1.68B | $1.78B | $6.50B | $3.27B | $3.65B | $3.58B |
| Property, plant and equipment | $650.0M | $709.2M | $718.9M | $712.9M | $715.5M | $918.1M | $1.08B | $1.33B | $1.68B | $1.63B |
| Goodwill | $3.81B | $4.06B | $3.91B | $3.99B | $3.91B | $4.12B | $3.97B | $4.17B | $7.60B | $8.56B |
| Other intangibles | $2.78B | $3.21B | $3.57B | $3.80B | $3.90B | $4.46B | $4.37B | $4.53B | $8.28B | $8.43B |
| Total assets | $10.20B | $11.91B | $12.08B | $12.66B | $12.12B | $13.69B | $16.73B | $17.71B | $22.63B | $22.55B |
| Accounts payable | $1.88B | $1.89B | $2.00B | $1.44B | $1.27B | $1.17B | $1.19B | $1.58B | $1.93B | $1.73B |
| Short-term debt | $14.4M | $3.5M | $3.0M | $57.9M | $23.0M | $24.2M | $188.3M | $193.8M | $218.9M | $209.1M |
| Total current liabilities | $2.54B | $2.54B | $2.60B | $2.74B | $2.57B | $2.42B | $3.59B | $3.48B | $4.04B | $3.80B |
| Long-term debt | $3.03B | $3.96B | $3.84B | $4.18B | $4.41B | $5.40B | $7.89B | $7.47B | $7.31B | $6.93B |
| Total liabilities | $6.82B | $7.95B | $7.83B | $8.43B | $8.56B | $9.51B | $12.71B | $12.66B | $13.11B | $12.68B |
| Retained earnings | -$5.88B | -$5.27B | -$4.90B | -$4.99B | -$5.50B | -$5.76B | -$5.55B | -$4.54B | -$626.2M | -$459.2M |
| Total equity | $2.99B | $3.54B | $4.01B | $4.00B | $3.35B | $3.06B | $3.23B | $4.59B | $8.86B | $9.32B |
Cash flow
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $537.8M | $492.6M | $614.6M | $625.7M | $726.6M | $318.7M | -$50.9M | $639.6M | $413.7M | $757.5M |
| Depreciation and amortisation | $482.2M | $420.0M | $421.1M | $426.7M | $516.4M | $585.3M | $716.5M | $736.0M | $737.0M | $555.1M |
| Stock-based compensation | $46.3M | $50.0M | $88.8M | $135.9M | $195.5M | $29.9M | $29.8M | $14.8M | $30.6M | $24.6M |
| Capital expenditure | $189.6M | $215.0M | $245.2M | $222.8M | $174.1M | $173.9M | $267.4M | $426.6M | $446.4M | $432.3M |
| Investing cash flow | $539.0M | -$128.4M | -$226.2M | -$118.2M | $269.7M | $2.44B | -$833.4M | -$454.0M | -$687.6M | -$1.16B |
| Financing cash flow | -$1.16B | -$426.8M | -$336.7M | -$469.3M | -$1.03B | -$2.80B | $877.3M | -$160.3M | $69.3M | $595.2M |
| Dividends paid | — | — | — | — | — | — | $195.2M | $63.3M | $93.8M | $93.6M |
| Buybacks | — | — | $350.6M | — | — | $0 | $4.5M | $0 | $0 | $36.3M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001024305-26-000048.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.65B | $6.84B | $6.29B | $4.72B | $4.63B | $5.30B | $5.55B | $6.12B | $5.89B | $5.81B |
| Gross profit | $4.62B | $4.12B | $3.79B | $2.73B | $2.77B | $3.37B | $3.55B | $3.94B | $3.82B | $3.65B |
| Net income | -$422.2M | -$168.8M | -$3.78B | -$1.01B | -$201.3M | $259.5M | $508.2M | $89.4M | -$367.9M | -$604.8M |
Recent filings and events
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Officer or director change Item 5.02
- Results announced Item 2.02
- Officer or director change Item 5.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Results announced Item 2.02
- Officer or director change Item 5.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Material impairment The company has written down the carrying value of an asset - often goodwill from an acquisition that did not work out. Item 2.06
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 2844
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| CL | COLGATE PALMOLIVE CO | $74.97B | 35.8x | 1.4% |
| EL | ESTEE LAUDER COMPANIES INC | $39.37B | 217.3x | 5.0% |
| KVUE | Kenvue Inc. | $37.59B | 25.8x | -2.1% |
| ELF | e.l.f. Beauty, Inc. | $6.74B | 259.6x | 24.6% |
| IPAR | INTERPARFUMS INC | $3.69B | 22.0x | 2.5% |
| EPC | EDGEWELL PERSONAL CARE Co | $1.29B | 52.9x | -1.3% |
| WALD | Waldencast plc | $100.3M | — | -0.7% |
| SLSN | SOLESENCE, INC. | $56.5M | 40.0x | 18.6% |